Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | -6.05% | -13.00% | +41.69% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 328M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 49.3 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 52.8 x |
P/E ratio 2024 * |
-3.41
x | P/E ratio 2025 * |
-3.35
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.92% |
Latest transcript on Solid Biosciences Inc.
1 day | -6.05% | ||
1 week | -13.00% | ||
Current month | -34.68% | ||
1 month | -34.44% | ||
3 months | +10.69% | ||
6 months | +314.29% | ||
Current year | +41.69% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 8.7 | -6.05% | 113,857 |
24-04-18 | 9.26 | -7.31% | 143,309 |
24-04-17 | 9.99 | +1.73% | 241,191 |
24-04-16 | 9.82 | -1.80% | 131,387 |
24-04-15 | 10 | -3.57% | 147,129 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.69% | 350M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- SLDB Stock